Task: Answer the multiple-choice question.
Question: Which drug exhibits a 5.391% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: CC(=O)Nc1ccc(OCc2cccc3ccccc23)cc1
b: CCN1C(=O)N[C@@H](c2cccc(F)c2)C(C(C)=O)=C1C
c: COc1cc(C(=S)N2CCOCC2)cc(OC)c1OC(=O)Cc1ccccc1
Answer: b. CCN1C(=O)N[C@@H](c2cccc(F)c2)C(C(C)=O)=C1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1C(=O)N[C@@H](c2cccc(F)c2)C(C(C)=O)=C1C
CCN1C(=O)N[C@@H](c2cccc(F)c2)C(C(C)=O)=C1C
(6S)-5-acetyl-3-ethyl-6-(3-fluorophenyl)-4-methyl-1,6-dihydropyrimidin-2-one